The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Osteoporosis
Interventions: DRUG: risedronate (including placebo)
Sponsor: University of Pittsburgh
Collaborators: Procter and Gamble|Aventis Pharmaceuticals